Yonsei University: Hepatitis trials
The registry lists 15 Hepatitis studies with Yonsei University as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 3 1Phase 4 9No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral TreatmentNot yet recruitingNCT06221657Phase 4
- The Establishment of Korean Hepatitis B Patients CohortRecruitingNCT04139850
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesStatus unknownNCT04584242Phase 4
- Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaStatus unknownNCT03892681Not applicable
- Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral ResistanceStatus unknownNCT03566030
- Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys®) in the Korean Chronic Hepatitis B(CHB) AdultsStatus unknownNCT02822547Phase 4
- Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis BCompletedNCT02263755
- Antiviral Efficacy of Switching to ETV Plus TDFStatus unknownNCT01597934Phase 4
- Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination TherapyStatus unknownNCT01595633Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated InterferonCompletedNCT01531166
- Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BStatus unknownNCT01270165Phase 3
- Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease PatientsStatus unknownNCT00823550Phase 4
- Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNACompletedNCT00625560Phase 4
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNACompletedNCT00625339Phase 4